You are here: Industry Insights > myeloma

News List

FDA Approves Xpovio (selinexor) for the Treatment of Patients with Relapsed or Refractory Multiple Myeloma drugs
July 04, 2019
FDA Approves Xpovio (selinexor) for the Treatment of Patients with Relapsed or Refractory Multiple Myeloma.
FDA Approves J&J's DARZALEX in Multiple Myeloma contractpharma
July 01, 2019
Results showed that DARZALEX significantly reduced the risk of disease progression or death by 44 percent.
Recommendations Issued for Imaging Use in Multiple Myeloma drugs
June 19, 2019
Recommendations Issued for Imaging Use in Multiple Myeloma.
Daratumumab Cuts Risk for Progression in Multiple Myeloma drugs
May 30, 2019
Daratumumab Cuts Risk for Progression in Multiple Myeloma.
Cellectar Receives FDA Fast Track Designation for CLR 131 in Relapsed or Refractory Multiple Myeloma drugs
May 20, 2019
Cellectar Receives FDA Fast Track Designation for CLR 131 in Relapsed or Refractory Multiple Myeloma.
J&J's fast-growing Darzalex lines up for 2nd 1L myeloma nod fiercepharma
December 06, 2018
SAN DIEGO—Johnson & Johnson’s Darzalex made multiple myeloma history this May when it became the first monoclonal antibody to score an FDA approval in newly diagnosed patients. And now, it’s looking to make it a repeat.
Revlimid shows significant PFS improvement in smoldering multiple myeloma pharmatimes
October 25, 2018
Celgene has announced results from an open-label phase II/III study led by the ECOG-ACRIN Cancer Research Group and sponsored by the National Cancer Institute (NCI).
NUS scientists develop new technology to treat myeloma patients biospectrumasia
August 15, 2018
With just a small amount of blood or bone marrow sample from patients, the platform is able to map the drug response that a set of drug combinations will have on the specific patient's cancer cells.
Johnson & Johnson's Darzalex snags landmark myeloma approval in first-line patients fiercepharma
May 09, 2018
Johnson & Johnson’s Darzalex just vaulted ahead of its myeloma competitors—and it has plenty of them...
UK researchers find 40 genes associated with myeloma pharmaceutical-technology
April 11, 2018
Researchers at the Institute of Cancer Research in the UK have discovered 40 genes involved in the development of myeloma, a form of blood cancer.

Previous page 1 2 3 4 Next page